Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony J Hinrich

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
RNA (New York, N.Y.)|September 10, 2024
Elevating microRNA levels by targeting biogenesis with steric-blocking antisense oligonucleotidesMallory A Havens, Anthony J Hinrich, Frank Rigo, et al.
Scientific Reports|September 13, 2023
Viral-like TLR3 induction of cytokine networks and α-synuclein are reduced by complement C3 blockade in mouse brainRia Thomas, Kyle J Connolly, Oeystein R Brekk, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 10, 2018
Targeting Amyloid-β Precursor Protein, APP, Splicing with Antisense Oligonucleotides Reduces Toxic Amyloid-β ProductionJennifer L Chang, Anthony J Hinrich, Brandon Roman, et al.
Molecular Therapy. Nucleic Acids|August 1, 2020
Splice-Switching Antisense Oligonucleotides Reduce LRRK2 Kinase Activity in Human LRRK2 Transgenic MiceJoanna A Korecka, Ria Thomas, Anthony J Hinrich, et al.
Human Molecular Genetics|July 2, 2019
Mitochondrial clearance and maturation of autophagosomes are compromised in LRRK2 G2019S familial Parkinson's disease patient fibroblastsJoanna A Korecka, Ria Thomas, Dan P Christensen, et al.
Nature Medicine|July 29, 2020
Therapeutic efficacy of antisense oligonucleotides in mouse models of CLN3 Batten diseaseJessica L Centa, Francine M Jodelka, Anthony J Hinrich, et al.
Nature Medicine|February 6, 2013
Rescue of hearing and vestibular function by antisense oligonucleotides in a mouse model of human deafnessJennifer J Lentz, Francine M Jodelka, Anthony J Hinrich, et al.
EMBO Molecular Medicine|February 24, 2016
Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense oligonucleotidesAnthony J Hinrich, Francine M Jodelka, Jennifer L Chang, et al.
Stem Cell Reports|January 1, 2019
Neurite Collapse and Altered ER Ca<sup>2+</sup> Control in Human Parkinson Disease Patient iPSC-Derived Neurons with LRRK2 G2019S MutationJoanna A Korecka, Sebastien Talbot, Teresia M Osborn, et al.
Molecular Psychiatry|March 17, 2022
Corticosteroid sensitization drives opioid addictionStephanie A Carmack, Janaina C M Vendruscolo, M Adrienne McGinn, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
RNA (New York, N.Y.)|September 10, 2024
Elevating microRNA levels by targeting biogenesis with steric-blocking antisense oligonucleotidesMallory A Havens, Anthony J Hinrich, Frank Rigo, et al.
Scientific Reports|September 13, 2023
Viral-like TLR3 induction of cytokine networks and α-synuclein are reduced by complement C3 blockade in mouse brainRia Thomas, Kyle J Connolly, Oeystein R Brekk, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 10, 2018
Targeting Amyloid-β Precursor Protein, APP, Splicing with Antisense Oligonucleotides Reduces Toxic Amyloid-β ProductionJennifer L Chang, Anthony J Hinrich, Brandon Roman, et al.
Molecular Therapy. Nucleic Acids|August 1, 2020
Splice-Switching Antisense Oligonucleotides Reduce LRRK2 Kinase Activity in Human LRRK2 Transgenic MiceJoanna A Korecka, Ria Thomas, Anthony J Hinrich, et al.
Human Molecular Genetics|July 2, 2019
Mitochondrial clearance and maturation of autophagosomes are compromised in LRRK2 G2019S familial Parkinson's disease patient fibroblastsJoanna A Korecka, Ria Thomas, Dan P Christensen, et al.
Nature Medicine|July 29, 2020
Therapeutic efficacy of antisense oligonucleotides in mouse models of CLN3 Batten diseaseJessica L Centa, Francine M Jodelka, Anthony J Hinrich, et al.
Nature Medicine|February 6, 2013
Rescue of hearing and vestibular function by antisense oligonucleotides in a mouse model of human deafnessJennifer J Lentz, Francine M Jodelka, Anthony J Hinrich, et al.
EMBO Molecular Medicine|February 24, 2016
Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense oligonucleotidesAnthony J Hinrich, Francine M Jodelka, Jennifer L Chang, et al.
Stem Cell Reports|January 1, 2019
Neurite Collapse and Altered ER Ca<sup>2+</sup> Control in Human Parkinson Disease Patient iPSC-Derived Neurons with LRRK2 G2019S MutationJoanna A Korecka, Sebastien Talbot, Teresia M Osborn, et al.
Molecular Psychiatry|March 17, 2022
Corticosteroid sensitization drives opioid addictionStephanie A Carmack, Janaina C M Vendruscolo, M Adrienne McGinn, et al.
Pageof 1